Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 0 0.000% | -695,000 (Position Closed) | Filing History |
| 2023-02-14 08:06 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Soleus Capital Master Fund, L.P. | 0 0.000% | -498,279 (Position Closed) | Filing History |
| 2023-02-14 07:55 am Purchase | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BANK OF AMERICA CORP BAC | 559,190 5.600% | 559,190 (New Position) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 777,287 7.793% | -310,098 (-28.52%) | Filing History |
| 2023-02-08 4:44 pm Purchase | 2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 730,018 7.300% | 212,468 (+41.05%) | Filing History |
| 2023-02-08 2:48 pm Purchase | 2022-12-30 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 713,505 7.200% | 713,505 (New Position) | Filing History |
| 2022-12-30 4:11 pm Sale | 2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 463,143 4.600% | -200,000 (-30.16%) | Filing History |
| 2022-09-02 10:18 am Purchase | 2022-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Soleus Capital Master Fund, L.P. | 498,279 5.000% | 498,279 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 332,384 3.400% | -402,298 (-54.76%) | Filing History |
| 2022-05-10 12:40 pm Purchase | 2022-05-04 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 517,550 5.200% | 517,550 (New Position) | Filing History |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 1,087,385 11.011% | 930,157 (+591.60%) | Filing History |
| 2022-02-14 08:48 am Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 755,482 7.700% | 32,745 (+4.53%) | Filing History |
| 2022-02-11 4:10 pm Sale | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | ORBIMED ADVISORS LLC | 0 0.000% | -484,525 (Position Closed) | Filing History |
| 2022-02-11 4:07 pm Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | REGENERON PHARMACEUTICALS INC. REGN | 180,910 1.840% | 180,910 (New Position) | Filing History |
| 2022-02-11 10:01 am Sale | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 695,000 7.100% | -105,000 (-13.12%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 734,682 7.500% | 30,405 (+4.32%) | Filing History |
| 2021-10-12 12:34 pm Sale | 2021-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | STATE STREET CORP STT | 204,762 2.090% | -816,324 (-79.95%) | Filing History |
| 2021-09-10 2:27 pm Purchase | 2021-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM | STATE STREET CORP STT | 1,021,086 10.410% | 1,021,086 (New Position) | Filing History |
| 2021-08-16 4:32 pm Sale | 2021-08-16 | 13G | Adverum Biotechnologies, Inc. ADVM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -950,238 (Position Closed) | Filing History |
| 2021-04-16 3:11 pm Unchanged | 2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 0 (Unchanged) | Filing History |